Tuesday, November 4, 2025 11/4/2025

Curry International Tuberculosis Center

Award Number: NU52PS910247
ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES
OPDIV: CDC
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: HEALTH SERVICES
PERIOD OF PERFORMANCE START DATE: 01/01/2023
PERIOD OF PERFORMANCE END DATE: 12/31/2027

Group Awards By:

View Award Description

Curry International Tuberculosis Center - Tuberculosis (TB) is one of the leading causes of death worldwide, and its elimination remains a vital public health priority of the Centers for Disease Control and Prevention (CDC). To assist CDC efforts, the University of California, San Francisco (UCSF) proposes that the Curry International Tuberculosis Center (CITC) be supported as a Tuberculosis Center of Excellence (TB COE) to continue training, technical assistance, and expert medical consultation to the TB healthcare workforce. CITC is currently funded by the CDC as a TB COE. During its 28-year history of creating, enhancing, and disseminating state-of-the-art resources and models of excellence for TB care and prevention, CITC has built a foundation of strong partnerships with TB programs, community provider networks, academia, and cross-disciplinary training centers to fulfill its mission. As a TB COE, CITC’s goal will be to support renewed momentum toward TB elimination in the US. During the award period, CITC will focus on two major activities defined in the notice of funding opportunity CDC-FRA-PS23-2301: 1) increasing knowledge, skills and abilities for TB and latent tuberculosis infection (LTBI) prevention and control through communication, education and training activities; and 2) improving sustainable, evidence-based TB and LTBI clinical practices and patient care through the provision of expert medical consultation. By the end of the project period, CITC expects to achieve the following short-term outcomes: 1) increased knowledge and skills related to TB and LTBI prevention and control among public health staff and healthcare workers; 2) increased access to and use of TB educational resources; 3) expanded availability and use of expert consultations for community provider networks serving populations at high-risk for LTBI and TB; and 4) increased understanding of national trends of TB patient care needs. The COVID-19 pandemic accelerated a pre-existing exodus of staff from the public health workforce, acutely noted among the nursing cadre, underscoring the crucial need for capacity-building to support TB care and prevention. The increasing complexity of TB cases (e.g., co-morbidities, drug resistance, etc.) presents additional clinical and programmatic challenges. The need is critical for expert centers that will strengthen local capacity through multi-disciplinary TB training, technical assistance, and expert consultation. The strategies and activities outlined in this proposal serve to address these needs by sustaining the highest standards of TB care, reducing health disparities in target populations, and advancing the goal of domestic TB elimination. CITC will continue to deliver state-of-the-art clinical and programmatic training and educational products that combine up-to-date, evidence-based clinical expertise, proven methods of case management and prevention, and best practice models of culturally-sensitive, person-centered care. A systematic approach to health education will guide the development of all courses and products, applying appropriate process and outcome evaluation methods, with reliance on ongoing needs assessment, collaboration, and communication with TB programs and partners to guide educational priorities. CITC will continue to provide expert medical, nursing, and programmatic consultation services, utilizing a corps of 33 consultants who represent the highest caliber of academic and clinical TB expertise. Training platforms will meet evolving learner styles with increased reliance on distance methodologies, using technology to enhance accessibility. CITC will increase its focus on LTBI outreach and engaging programs and community providers to advance equitable access and quality of care for populations at high-risk. As CITC nears its 3rd decade of service to the healthcare community, it will continue an exceptional tradition of excellence, innovation, and collaboration in the pursuit of TB elimination.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $1,308,101 )
2025	2025	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	02	3	9/22/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$260,870
2025	2025	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	01	3	7/28/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2025	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	00	3	12/6/2024	NON-COMPETING CONTINUATION	$1,047,231
2025	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	02	3	9/22/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	00	3	12/6/2024	NON-COMPETING CONTINUATION	$0
2025	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	01	3	7/28/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	01	3	7/28/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	02	3	9/22/2025	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2025	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	00	3	12/6/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,308,101

Issue Date FY: 2024 ( Subtotal = $1,308,101 )
2024	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 Folsom St Ste 425	San Francisco	CA	94143	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	00	2	12/20/2023	NON-COMPETING CONTINUATION	$667,880
2024	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	01	2	6/28/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$640,221
2024	2023	Regents of the University of California, San Francisco, The	1855 Folsom St Ste 425	San Francisco	CA	94143	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	03	1	11/29/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	-$1,332,010
2024	2023	Regents of the University of California, San Francisco, The	1855 Folsom St Ste 425	San Francisco	CA	94143	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	04	1	12/13/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$1,332,010
2024	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 FOLSOM ST STE 425	SAN FRANCISCO	CA	94103	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	01	2	6/28/2024	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2024	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE	1855 Folsom St Ste 425	San Francisco	CA	94143	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	00	2	12/20/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,308,101

Issue Date FY: 2023 ( Subtotal = $1,332,010 )
2023	2023	Regents of the University of California, San Francisco, The	1855 Folsom St Ste 425	San Francisco	CA	94143	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	01	1	4/6/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
2023	2023	Regents of the University of California, San Francisco, The	1855 Folsom St Ste 425	San Francisco	CA	94143	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	00	1	12/16/2022	NEW	$1,332,010
2023	2023	Regents of the University of California, San Francisco, The	1855 Folsom St Ste 425	San Francisco	CA	94143	SAN FRANCISCO	USA	Tuberculosis Demonstration, Research, Public and Professional Education	02	1	7/20/2023	ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS)	$0
														Subtotal = $1,332,010

Grand Total All Awards = $3,948,212

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Curry International Tuberculosis Center

Award Number: NU52PS910247

ORGANIZATION: NATIONAL CENTER FOR PREVENTION SERVICES

OPDIV: CDC

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: HEALTH SERVICES

PERIOD OF PERFORMANCE START DATE: 01/01/2023

PERIOD OF PERFORMANCE END DATE: 12/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer